Related Experiment Video

Updated: Apr 15, 2026

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
06:19

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches

Published on: June 16, 2023

4.0K

Targeting ion channels for cancer therapy by repurposing the approved drugs

Vijay Pralhad Kale1, Shantu G Amin1, Manoj K Pandey1

  • 1Department of Pharmacology, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.

Biochimica Et Biophysica Acta
|April 7, 2015
PubMed

Insights

Drug repurposing offers a promising avenue for cancer treatment by targeting ion channels. Existing FDA-approved drugs, with known safety profiles, could be repurposed to inhibit ion channels, potentially leading to safer and more cost-effective cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Ion channels play a crucial role in oncogenesis.
  • Many clinically approved drugs interact with ion channels as off-targets.
  • Targeting ion channels presents a therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To investigate the potential of repurposing existing FDA-approved drugs for cancer treatment by targeting ion channels.
  • To explore the feasibility of utilizing advanced bioinformatics and omics data for drug repurposing in oncology.

Main Methods:

  • Leveraging advanced bioinformatics techniques.
  • Analyzing open-access data on FDA-approved drugs.
  • Utilizing omics data from various cancer types.

Main Results:

  • Identified potential for repurposing clinically approved drugs to inhibit ion channels for cancer therapy.
  • Demonstrated the utility of bioinformatics and omics data in identifying novel therapeutic strategies.
  • Highlighted the economic and safety benefits of drug repurposing.

Conclusions:

  • Drug repurposing is a viable strategy to develop safer and more cost-effective cancer treatments.
  • Targeting ion channels with repurposed drugs holds significant promise for oncology.
  • Integration of bioinformatics and omics data accelerates the discovery of new cancer therapies.
Keywords:
Ca++channelsCancerDrug repurposeIon channelsK+channels

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

4.6K
Capturing the Interaction Kinetics of an Ion Channel Protein with Small Molecules by the Bio-layer Interferometry Assay10:41

Capturing the Interaction Kinetics of an Ion Channel Protein with Small Molecules by the Bio-layer Interferometry Assay

Published on: March 7, 2018

8.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.9K
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
5.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism....
9.2K